Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Prepaid Assets of $6.8 million for Q1 2026, up 56.84% on a QoQ basis from $4.3 million in Q4 2025, and down 23.11% year-over-year from $8.9 million in Q1 2025.
Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Prepaid Assets history runs 15 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- Quarterly Prepaid Assets fell 23.11% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 23.11% YoY) and the FY2025 annual result came in at $8.6 million, down 30.8% from the prior year.
- Prepaid Assets was $6.8 million for Q1 2026 at Enanta Pharmaceuticals, up from $4.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $17.9 million in Q4 2022 and bottomed at $4.3 million in Q4 2025.
- A 5-year average of $12.0 million and a median of $12.4 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 55.97% — and 2025, when it tumbled 59.36%.
- Enanta Pharmaceuticals' Prepaid Assets stood at $17.9 million in 2022, then fell by 26.2% to $13.2 million in 2023, then fell by 19.34% to $10.7 million in 2024, then plunged by 59.36% to $4.3 million in 2025, then surged by 56.84% to $6.8 million in 2026.
- Business Quant data shows ENTA's Prepaid Assets at $6.8 million in Q1 2026, $4.3 million in Q4 2025, and $8.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 10.68 Mn |
| Sep 30, 2024 | 12.41 Mn |
| Jun 30, 2024 | 15.26 Mn |
| Mar 31, 2024 | 10.93 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 13.26 Mn |
| Jun 30, 2023 | 17.07 Mn |
| Mar 31, 2023 | 14.48 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | 13.45 Mn |
| Jun 30, 2022 | 11.54 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 11.51 Mn |
| Sep 30, 2021 | 14.19 Mn |
| Jun 30, 2021 | 12.14 Mn |